BIOLASE Performance
| BIOLDelisted Stock | USD 0.05 0.02 27.46% |
The firm shows a Beta (market volatility) of 3.85, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BIOLASE will likely underperform. BIOLASE now shows a risk of 0.0%. Please confirm BIOLASE potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if BIOLASE will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days BIOLASE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, BIOLASE is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 4.2 M |
BIOLASE |
BIOLASE Relative Risk vs. Return Landscape
If you would invest 4.65 in BIOLASE on September 21, 2024 and sell it today you would earn a total of 0.00 from holding BIOLASE or generate 0.0% return on investment over 90 days. BIOLASE is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than BIOLASE, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BIOLASE Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BIOLASE's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BIOLASE, and traders can use it to determine the average amount a BIOLASE's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BIOL |
Based on monthly moving average BIOLASE is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BIOLASE by adding BIOLASE to a well-diversified portfolio.
BIOLASE Fundamentals Growth
BIOLASE Stock prices reflect investors' perceptions of the future prospects and financial health of BIOLASE, and BIOLASE fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BIOLASE Stock performance.
| Return On Equity | -5.05 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (0.44) % | |||
| Operating Margin | (0.45) % | |||
| Current Valuation | 13.65 M | |||
| Shares Outstanding | 33.4 M | |||
| Price To Earning | (7.23) X | |||
| Price To Book | 0.77 X | |||
| Price To Sales | 0.1 X | |||
| Revenue | 49.16 M | |||
| EBITDA | (15.14 M) | |||
| Cash And Equivalents | 9.96 M | |||
| Cash Per Share | 1.39 X | |||
| Total Debt | 17.91 M | |||
| Debt To Equity | 1.07 % | |||
| Book Value Per Share | (0.06) X | |||
| Cash Flow From Operations | (14.09 M) | |||
| Earnings Per Share | (11.97) X | |||
| Total Asset | 35.1 M | |||
| Retained Earnings | (316.8 M) | |||
| Current Asset | 34.8 M | |||
| Current Liabilities | 15.11 M | |||
About BIOLASE Performance
By examining BIOLASE's fundamental ratios, stakeholders can obtain critical insights into BIOLASE's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that BIOLASE is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California. Biolase operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 158 people.Things to note about BIOLASE performance evaluation
Checking the ongoing alerts about BIOLASE for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BIOLASE help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BIOLASE is not yet fully synchronised with the market data | |
| BIOLASE has some characteristics of a very speculative penny stock | |
| BIOLASE has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 49.16 M. Net Loss for the year was (20.63 M) with profit before overhead, payroll, taxes, and interest of 16.53 M. | |
| BIOLASE currently holds about 9.96 M in cash with (14.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing BIOLASE's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BIOLASE's stock is overvalued or undervalued compared to its peers.
- Examining BIOLASE's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BIOLASE's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BIOLASE's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BIOLASE's stock. These opinions can provide insight into BIOLASE's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in BIOLASE Stock
If you are still planning to invest in BIOLASE check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BIOLASE's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |